Literature DB >> 24619377

Prostate cancer: cabozantinib reduces pain and narcotic use in men with CRPC.

Melanie Clyne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24619377     DOI： 10.1038/nrurol.2014.57

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort.

Authors:  Ethan Basch; Karen A Autio; Matthew R Smith; Antonia V Bennett; Aaron L Weitzman; Christian Scheffold; Christopher Sweeney; Dana E Rathkopf; David C Smith; Daniel J George; Celestia S Higano; Andrea L Harzstark; A Oliver Sartor; Michael S Gordon; Nicholas J Vogelzang; Johann S de Bono; Naomi B Haas; Paul G Corn; Frauke Schimmoller; Howard I Scher
Journal:  Eur Urol       Date:  2014-02-20       Impact factor: 20.096
  1 in total
  1 in total

1.  Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer.

Authors:  Deborah R Kaye; Peter A Pinto; Fabiola Cecchi; Joseph Reilly; Alice Semerjian; Daniel C Rabe; Gopal Gupta; Peter L Choyke; Donald P Bottaro
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.